148 related articles for article (PubMed ID: 3892514)
1. [Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation].
Horoszek-Maziarz S; Berliński E; Jaromczyk-Slisz J; Rachoń K; Wójcikowski C; Słomiński M; Orłowska-Kunikowska E; Krupa-Wojciechowska B
Pol Tyg Lek; 1985 May; 40(18):516-8. PubMed ID: 3892514
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults].
Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME
Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349
[No Abstract] [Full Text] [Related]
3. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
4. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
[No Abstract] [Full Text] [Related]
5. [Glibornurid in treatment of diabetes mellitus].
Rojszykowa E; Wrzesimski W
Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
Rupprecht E; König E; Limmer J
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
[No Abstract] [Full Text] [Related]
7. [Diamicron in the treatment of diabetes mellitus type 2].
Balabolkin MI; Morozova TP; Chachiashvili MV
Sov Med; 1987; (7):21-2. PubMed ID: 3317910
[No Abstract] [Full Text] [Related]
8. [New aspects of therapy with oral antidiabetic agents].
Haslbeck M
Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
[No Abstract] [Full Text] [Related]
9. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
Sigroth K; Steen B; Svanborg A
Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
[No Abstract] [Full Text] [Related]
10. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
Al-Ozairi E; Sibal L; Home P
Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288
[No Abstract] [Full Text] [Related]
11. Pioglitazone/glimepiride (Duetact) for diabetes.
Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
[No Abstract] [Full Text] [Related]
12. Oral management of uncomplicated maturity onset diabetes.
Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
[No Abstract] [Full Text] [Related]
13. [Limited effect of antidiabetics on type 2 diabetes].
Lindeberg S
Lakartidningen; 1998 Dec; 95(49):5605-6. PubMed ID: 9863297
[No Abstract] [Full Text] [Related]
14. Use oral hypoglycemics with caution..
Jackson JE; Bressler R
Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057
[No Abstract] [Full Text] [Related]
15. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
Emanueli A; Molari E; Pirola LC; Caputo G
Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
[No Abstract] [Full Text] [Related]
16. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
Buse JB
Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
[No Abstract] [Full Text] [Related]
17. [Glimepiride in daily practice].
Jasik M
Przegl Lek; 2003; 60(6):409-12. PubMed ID: 14974179
[TBL] [Abstract][Full Text] [Related]
18. A miracle of salamization: positive divided by two equals negative.
Iwamoto Y
Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
[No Abstract] [Full Text] [Related]
19. Do we need new drugs for the treatment of type 2 diabetes mellitus?
Vervoort G; Tack CJ
Neth J Med; 2007 May; 65(5):157-9. PubMed ID: 17519510
[No Abstract] [Full Text] [Related]
20. [Cyclohexamide. A new oral hypoglycemic agent].
Villaseñor A; Parra A; López Amor E; Rull JA; Lozano-Castañeda O
Rev Invest Clin; 1967; 19(2):149-57. PubMed ID: 5317602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
